atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit
06 Ottobre 2023 - 10:05PM
atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage
biopharmaceutical company aiming to transform the treatment of
mental health disorders, will participate in the Jefferies
Inaugural Biotech CNS/Neuro Summit being held from October 11-12,
2023.
Details of the company’s participation is as follows:
Jefferies Inaugural Biotech
CNS/Neuro Summit
Format: Fireside Chat
Date and Time: Wednesday, October
11th at 8:30 A.M. ET
Location: New York, NY
A webcast of the company’s fireside chat will be available on
atai’s website under Events on the Investors section of the atai
website: https://ir.atai.life/news-events/events/. A replay will be
available following the live event.
About atai Life Sciencesatai is a
clinical-stage biopharmaceutical company aiming to transform the
treatment of mental health disorders and was founded as a response
to the significant unmet need and lack of innovation in the mental
health treatment landscape. atai is dedicated to efficiently
developing innovative therapeutics to treat depression, anxiety,
addiction, and other mental health disorders.
By pooling resources and best practices, atai aims to
responsibly accelerate the development of new medicines to achieve
clinically meaningful and sustained behavioral change in mental
health patients.
atai's vision is to heal mental health disorders so that
everyone, everywhere can live a more fulfilled life. For more
information, please visit www.atai.life.
Contact InformationInvestor
Contact:IR@atai.life
Media Contact:PR@atai.life
Grafico Azioni ATAI Life Sciences NV (NASDAQ:ATAI)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni ATAI Life Sciences NV (NASDAQ:ATAI)
Storico
Da Giu 2023 a Giu 2024